tiprankstipranks
Advertisement
Advertisement

CRVO Stock Latest News

CervoMed’s neflamapimod gains UK Innovation Passport
Company AnnouncementsCervoMed’s neflamapimod gains UK Innovation Passport
2d ago
8K
CRVO
CervoMed advances neflamapimod strategy with new DLB data
PremiumCompany Announcements
CervoMed advances neflamapimod strategy with new DLB data
22d ago
8K
CRVO
CervoMed Completes Enrollment in Phase 2a Neflamapimod Trial
PremiumCompany Announcements
CervoMed Completes Enrollment in Phase 2a Neflamapimod Trial
27d ago
8K
CRVO
CervoMed completes enrollment in neflamapimod study
PremiumThe Fly
CervoMed completes enrollment in neflamapimod study
28d ago
CRVO
CervoMed’s DLB Trial Milestone: What CRVO Investors Should Watch Next
PremiumCompany Announcements
CervoMed’s DLB Trial Milestone: What CRVO Investors Should Watch Next
28d ago
CRVO
CervoMed registers to sell 10.08M shares of common stock for holders
PremiumThe FlyCervoMed registers to sell 10.08M shares of common stock for holders
1M ago
CRVO
CervoMed Raises $10 Million in Direct Offering
Premium
Company Announcements
CervoMed Raises $10 Million in Direct Offering
1M ago
8K
CRVO
CervoMed announces $10M registered direct offering priced at-the-market
Premium
The Fly
CervoMed announces $10M registered direct offering priced at-the-market
2M ago
CRVO
CervoMed Gains New Patent for Neflamapimod Dementia Therapy
PremiumCompany Announcements
CervoMed Gains New Patent for Neflamapimod Dementia Therapy
2M ago
8K
CRVO
CervoMed receives notice of allowance from USPTO on neflamapimod
PremiumThe Fly
CervoMed receives notice of allowance from USPTO on neflamapimod
2M ago
CRVO
CervoMed Posts Updated Investor Presentation and Business Overview
PremiumCompany Announcements
CervoMed Posts Updated Investor Presentation and Business Overview
2M ago
8K
CRVO
CervoMed Announces Private Placement to Advance Neurology Pipeline
PremiumCompany Announcements
CervoMed Announces Private Placement to Advance Neurology Pipeline
2M ago
8K
CRVO
CervoMed announces $10.5M private placement
PremiumThe FlyCervoMed announces $10.5M private placement
2M ago
CRVO
CervoMed announces $10.5M private placement
Premium
The Fly
CervoMed announces $10.5M private placement
2M ago
CRVO
CervoMed Shareholders Back Board, Pay and Incentive Plan
Premium
Company Announcements
CervoMed Shareholders Back Board, Pay and Incentive Plan
2M ago
8K
CRVO
CervoMed: FDA-Aligned Phase 3 Path and Multiple Catalysts Underscore Buy Rating, Price Target Held at $27
PremiumRatings
CervoMed: FDA-Aligned Phase 3 Path and Multiple Catalysts Underscore Buy Rating, Price Target Held at $27
3M ago
CRVO
Boris Peaker Reiterates Buy on Neflamapimod Developer, Backs $20 Price Target on Pivotal DLB Phase III and Broad 2026 Clinical Catalysts
PremiumRatings
Boris Peaker Reiterates Buy on Neflamapimod Developer, Backs $20 Price Target on Pivotal DLB Phase III and Broad 2026 Clinical Catalysts
3M ago
CRVO
CervoMed Highlights Q1 Results and Neflamapimod Progress
PremiumCompany Announcements
CervoMed Highlights Q1 Results and Neflamapimod Progress
3M ago
8K
CRVO
CervoMed price target lowered to $9 from $11 at Roth Capital
PremiumThe Fly
CervoMed price target lowered to $9 from $11 at Roth Capital
3M ago
CRVO
CRVO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsCRVO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
CRVO
Neflamapimod’s MRI and Connectivity Data Support Disease‑Modifying Potential in Dementia With Lewy Bodies and Underscore Buy Rating on CervoMed
Premium
Ratings
Neflamapimod’s MRI and Connectivity Data Support Disease‑Modifying Potential in Dementia With Lewy Bodies and Underscore Buy Rating on CervoMed
3M ago
CRVO
CervoMed Highlights Positive Phase 2b Neflamapimod MRI Results
Premium
Company Announcements
CervoMed Highlights Positive Phase 2b Neflamapimod MRI Results
4M ago
8K
CRVO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >